Vance B. Matthews

599 total citations
19 papers, 438 citations indexed

About

Vance B. Matthews is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Vance B. Matthews has authored 19 papers receiving a total of 438 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Molecular Biology and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Vance B. Matthews's work include Blood Pressure and Hypertension Studies (4 papers), Diabetes Treatment and Management (4 papers) and Adipose Tissue and Metabolism (3 papers). Vance B. Matthews is often cited by papers focused on Blood Pressure and Hypertension Studies (4 papers), Diabetes Treatment and Management (4 papers) and Adipose Tissue and Metabolism (3 papers). Vance B. Matthews collaborates with scholars based in Australia, Germany and Canada. Vance B. Matthews's co-authors include Kevin D. Croft, Markus P. Schlaich, Jonathan M. Hodgson, Lakshini Y. Herat, Natalie C. Ward, Aidilla Mubarak, Michael Considine, David L. Hare, George Jerums and Steve Selig and has published in prestigious journals such as Diabetes Care, Journal of Agricultural and Food Chemistry and Scientific Reports.

In The Last Decade

Vance B. Matthews

19 papers receiving 429 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Vance B. Matthews Australia	11	115	107	105	65	53	19	438
C. Di Filippo Italy	11	74 0.6×	105 1.0×	43 0.4×	88 1.4×	95 1.8×	14	406
Roya Naderi Iran	15	128 1.1×	163 1.5×	70 0.7×	44 0.7×	42 0.8×	60	580
Farhad Ghadiri Soufi Iran	14	160 1.4×	233 2.2×	77 0.7×	70 1.1×	24 0.5×	27	631
Renáta Szabó Hungary	13	114 1.0×	167 1.6×	64 0.6×	72 1.1×	46 0.9×	43	500
Ana Paula Bouças Brazil	15	216 1.9×	155 1.4×	116 1.1×	90 1.4×	41 0.8×	28	654
Dominga Lapi Italy	16	185 1.6×	189 1.8×	62 0.6×	80 1.2×	26 0.5×	51	639
Weihua Wu China	10	72 0.6×	171 1.6×	107 1.0×	52 0.8×	19 0.4×	14	474
V. Marinescu United States	9	148 1.3×	90 0.8×	80 0.8×	162 2.5×	26 0.5×	16	595
Akinori Kogure Japan	14	341 3.0×	128 1.2×	105 1.0×	80 1.2×	47 0.9×	26	589
Justin D. La Favor United States	12	165 1.4×	160 1.5×	134 1.3×	145 2.2×	32 0.6×	23	578

Countries citing papers authored by Vance B. Matthews

Since Specialization

Citations

This map shows the geographic impact of Vance B. Matthews's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vance B. Matthews with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vance B. Matthews more than expected).

Fields of papers citing papers by Vance B. Matthews

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vance B. Matthews. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vance B. Matthews. The network helps show where Vance B. Matthews may publish in the future.

Co-authorship network of co-authors of Vance B. Matthews

This figure shows the co-authorship network connecting the top 25 collaborators of Vance B. Matthews. A scholar is included among the top collaborators of Vance B. Matthews based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vance B. Matthews. Vance B. Matthews is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Herat, Lakshini Y., et al.. (2023). Comparing and Contrasting the Effects of the SGLT Inhibitors Canagliflozin and Empagliflozin on the Progression of Retinopathy. Frontiers in Bioscience-Landmark. 28(4). 83–83. 8 indexed citations

Kannenkeril, Dennis, Janis M. Nolde, Márcio Galindo Kiuchi, et al.. (2022). Retinal Capillary Damage Is Already Evident in Patients With Hypertension and Prediabetes and Associated With HbA1c Levels in the Nondiabetic Range. Diabetes Care. 45(6). 1472–1475. 6 indexed citations

Lugo‐Gavidia, Leslie Marisol, Dylan Burger, Janis M. Nolde, et al.. (2022). Platelet-derived extracellular vesicles correlate with therapy-induced nocturnal blood pressure changes. Journal of Hypertension. 40(11). 2210–2218. 4 indexed citations

Lugo‐Gavidia, Leslie Marisol, Revathy Carnagarin, Dylan Burger, et al.. (2022). Circulating platelet‐derived extracellular vesicles correlate with night‐time blood pressure and vascular organ damage and may represent an integrative biomarker of vascular health. Journal of Clinical Hypertension. 24(6). 738–749. 10 indexed citations

Herat, Lakshini Y., et al.. (2022). Determining the Role of SGLT2 Inhibition with Dapagliflozin in the Development of Diabetic Retinopathy. Frontiers in Bioscience-Landmark. 27(12). 321–321. 13 indexed citations

Lugo‐Gavidia, Leslie Marisol, Dylan Burger, Vance B. Matthews, et al.. (2021). Role of Microparticles in Cardiovascular Disease: Implications for Endothelial Dysfunction, Thrombosis, and Inflammation. Hypertension. 77(6). 1825–1844. 45 indexed citations

Frost, Shaun, Janis M. Nolde, Anu Joyson, et al.. (2021). Retinal capillary rarefaction is associated with arterial and kidney damage in hypertension. Scientific Reports. 11(1). 1001–1001. 17 indexed citations

Kiuchi, Márcio Galindo, Shaojie Chen, Humberto Villacorta, et al.. (2020). Renal denervation as a synergistic tool for the treatment of polymorphic ventricular ectopic beats. Medicine. 99(29). e21098–e21098. 1 indexed citations

Carnagarin, Revathy, Ricardo Fonseca, Dagmara Hering, et al.. (2019). May Measurement Month 2017: an analysis of blood pressure screening results from Australia—South-East Asia and Australasia. European Heart Journal Supplements. 21(Supplement_D). D14–D16. 6 indexed citations

10.

Anderton, Ryan S., Bruno P. Meloni, Gilles J. Guillemin, et al.. (2019). Microglia are both a source and target of extracellular cyclophilin A. Heliyon. 5(9). e02390–e02390. 9 indexed citations

11.

Matthews, Vance B., et al.. (2019). SGLT-2 inhibitor induced sympathoinhibition: a novel mechanism for cardiorenal protection. Obesity Research & Clinical Practice. 13(3). 287–287. 10 indexed citations

12.

Matthews, Vance B., et al.. (2018). Long-Term Dietary Nitrate Supplementation Does Not Prevent Development of the Metabolic Syndrome in Mice Fed a High-Fat Diet. International Journal of Endocrinology. 2018. 1–8. 10 indexed citations

13.

Tan, Si, José A. Caparrós‐Martín, Vance B. Matthews, et al.. (2018). Isoquercetin and inulin synergistically modulate the gut microbiome to prevent development of the metabolic syndrome in mice fed a high fat diet. Scientific Reports. 8(1). 10100–10100. 54 indexed citations

14.

Herat, Lakshini Y., Vance B. Matthews, P. Elizabeth Rakoczy, Revathy Carnagarin, & Markus P. Schlaich. (2018). Focusing on Sodium Glucose Cotransporter-2 and the Sympathetic Nervous System: Potential Impact in Diabetic Retinopathy. International Journal of Endocrinology. 2018. 1–8. 23 indexed citations

15.

Rudnicka, Caroline, Joanne E. Curran, Matthew P. Johnson, et al.. (2017). ADAM19: A Novel Target for Metabolic Syndrome in Humans and Mice. Mediators of Inflammation. 2017. 1–9. 10 indexed citations

16.

Croft, Kevin D., et al.. (2014). Green coffee polyphenols do not attenuate features of the metabolic syndrome and improve endothelial function in mice fed a high fat diet. Archives of Biochemistry and Biophysics. 559. 46–52. 30 indexed citations

17.

Mubarak, Aidilla, Jonathan M. Hodgson, Michael Considine, Kevin D. Croft, & Vance B. Matthews. (2013). Supplementation of a High-Fat Diet with Chlorogenic Acid Is Associated with Insulin Resistance and Hepatic Lipid Accumulation in Mice. Journal of Agricultural and Food Chemistry. 61(18). 4371–4378. 70 indexed citations

18.

Jowett, Jeremy B. M., Yasunori Okada, Peter J. Leedman, et al.. (2012). ADAM28 is elevated in humans with the metabolic syndrome and is a novel sheddase of human tumour necrosis factor‐α. Immunology and Cell Biology. 90(10). 966–973. 20 indexed citations

19.

Levinger, Itamar, Craig A. Goodman, Vance B. Matthews, et al.. (2008). BDNF, Metabolic Risk Factors, and Resistance Training in Middle-Aged Individuals. Medicine & Science in Sports & Exercise. 40(3). 535–541. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact